Peter York

USPTO Granted Patents = 23 (Patent Applications = 3)

CIPO Patents = 4

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.6

ph-index = 9

Forward Citations = 463(Granted Patents)

Location History:

Ilkley, W. Yorkshire, GB (1998)
West Yorkshire, GB (2002)
Illkley, GB (2019)
Ilkley, GB (1990 - 2021)

Company Filing History:

Bradford Particle Design Limited

patent

4. 1 out of 21

University of Bradford

Inhale Therapeutic Systems, Inc.

patents

Years Active: 1990-2021

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10945972 - Particulate materials (2021-03-16),

2. 10798955 - Compositions of particulate coformulation (2020-10-13),

3. 10251881 - Particulate materials (2019-04-09),

4. 10188614 - Particulate materials (2019-01-29),

5. 9700529 - Particulate materials (2017-07-11),

6. 9616060 - Particulate materials (2017-04-11),

7. 9339459 - Particulate materials (2016-05-17),

8. 9120031 - Compositions of particulate coformulation (2015-09-01),

9. 8828359 - Particulate materials (2014-09-09),

10. 8470301 - Particulate materials (2013-06-25),

11. 8273330 - Particulate materials (2012-09-25),

12. 8080236 - Particulate materials (2011-12-20),

13. 7582284 - Particulate materials (2009-09-01),

14. 7150766 - Method of particle formation (2006-12-19),

15. 7115280 - Particle formation methods and their products (2006-10-03),

Title: Innovations by Peter York in Particulate Materials

Introduction

Peter York, an innovative inventor based in Ilkley, GB, holds an impressive portfolio of 23 patents. His work primarily focuses on the development of particulate materials and their applications, contributing significantly to advancements in drug delivery systems.

Latest Patents

Peter's latest patents showcase his expertise in particulate substances. One notable invention pertains to active substances in particulate form, which discusses methods for preparing them and their potential applications. This invention specifically provides particulate powders that can enhance the delivery process when used with dry powder inhalers (DPI). Another significant patent from Peter involves compositions of particulate coformulation. In this embodiment, the composition includes particles that comprise an active substance and an additive, designed in such a way that the additive concentration increases from the center to the surface of the particle. This innovative approach allows for the formation of a protective surface layer around the active substance, optimizing its delivery and effectiveness.

Career Highlights

Throughout his career, Peter has been associated with notable companies like Nektar Therapeutics and Aps Research Limited. His work in these companies has greatly influenced the field of particulate materials and their delivery mechanisms, marking him as a key contributor to advancements in pharmaceutical technologies.

Collaborations

Peter has collaborated with several talented individuals in the field, including Mazen H. Hanna and Andreas Kordikowski. These partnerships have facilitated the exchange of innovative ideas and advancements in the development of particulate coformulations.

Conclusion

Peter York's contributions to the field of particulate materials and their applications in drug delivery are significant, as evidenced by his numerous patents and collaborations. His ongoing dedication to innovation in this area promises to continue shaping the future of pharmaceutical technology.

This text is generated by artificial intelligence and may not be accurate.